A Review About Pembrolizumab in First-Line Treatment of Advanced NSCLC: Focus on KEYNOTE Studies
暂无分享,去创建一个
Xiaochun Zhang | Li Wang | Jialin Qu | Deze Zhao | M. Jiang | Yuyang Wang | Feng Zhang | Jing Li
暂无分享,去创建一个
Xiaochun Zhang | Li Wang | Jialin Qu | Deze Zhao | M. Jiang | Yuyang Wang | Feng Zhang | Jing Li